JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 29, 2006; DOI: 10.1124/jpet.106.113837


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.113837v1
320/3/1153    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deng, R.
Right arrow Articles by Yan, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deng, R.
Right arrow Articles by Yan, B.


Received for publication September 12, 2006.
Revised November 22, 2006.
Accepted for publication November 27, 2006.

Hypolipidemic Agent Guggulsterone Regulates the Expression of Human Bile Salt Export Pump: Dominance of Transactivation over FXR-Mediated antagonism

Ruitang Deng 1*, Dongfang Yang 1, Amy Radke 1, Jian Yang 1, Bingfang Yan 1

1 University of Rhode Island

* Address correspondence to: E-mail: dengr{at}mail.uri.edu

Abstract

Conversion of cholesterol to bile acids in the liver is initiated by the rate-limiting enzyme cholesterol 7{alpha}-hydroxylase (CYP7A1) and excretion of bile acids from the liver is mediated by bile salt export pump (BSEP). The expression of CYP7A1 and BSEP is coordinately regulated by a negative feedback and positive feed-forward mechanism, respectively, through bile acids-mediated activation of farsenoid X receptor (FXR). It is well established that hypolipidemic agent guggulsterone is an FXR antagonist and downregulates FXR target genes. In this study, however, we have demonstrated that guggulsterone synergistically induced the expression of BSEP in cells treated with FXR agonists bile acids. Dissection study located in the BSEP promoter an AP-1 site (activating protein-1) supporting the action of guggulsterone. Deletion or mutation of the AP-1 element diminished whereas insertion of the AP-1 element into a heterologous promoter enhanced activation of the promoter by guggulsterone. Selective c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) inhibitors markedly decreased the transactivation, suggesting an involvement of AP-1 activation pathway in the upregulation of BSEP by guggulsterone. Consistent with its FXR antagonism, guggulsterone antagonized bile acids-mediated transactivation of BSEP promoter when the AP-1 element was disrupted. In conclusion, guggulsterone regulates BSEP expression through composite mechanisms and the transactivation through the AP-1 element is dominant over the FXR-mediated antagonism. The upregulation of BSEP expression by guggulsterone without activating FXR pathway as an FXR agonist does to suppress CYP7A1 expression represents a possible mechanism for guggulsterone-mediated hypolipidemic effect.


Key words: BSEP, Bile acids, FXR, Guggulsterone, Transcription, gene regulation


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
X. Song, R. Kaimal, B. Yan, and R. Deng
Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression
J. Lipid Res., May 1, 2008; 49(5): 973 - 984.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.